Table of Contents

company-logo

Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various forms of cancer. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was incorporated in 1994 and is based in Sydney, Australia.

Kazia Therapeutics Dividend Announcement

• Kazia Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Kazia Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Kazia Therapeutics Dividend History

Kazia Therapeutics Dividend Yield

Kazia Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Kazia Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Kazia Therapeutics Financial Ratios

P/E ratio-15.73
PEG ratio-1.00
P/B ratio46.90
ROE-181.34%
Payout ratio0.00%
Current ratio0.71
Quick ratio0.71
Cash Ratio0.31

Kazia Therapeutics Dividend FAQ

Does Kazia Therapeutics stock pay dividends?
Kazia Therapeutics does not currently pay dividends to its shareholders.
Has Kazia Therapeutics ever paid a dividend?
No, Kazia Therapeutics has no a history of paying dividends to its shareholders. Kazia Therapeutics is not known for its dividend payments.
Why doesn't Kazia Therapeutics pay dividends?
There are several potential reasons why Kazia Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Kazia Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Kazia Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Kazia Therapeutics a dividend aristocrat?
Kazia Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Kazia Therapeutics a dividend king?
Kazia Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Kazia Therapeutics a dividend stock?
No, Kazia Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Kazia Therapeutics stocks?
To buy Kazia Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Kazia Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.